product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human MMP-3 Protein, CF
catalog :
513-MP-010
quantity :
10 ug
price :
444 USD
more info or order :
citations: 10
Reference
Levengood M, Carosino C, Zhang X, Lucas S, Ortiz D, Westendorf L, et al. Preclinical development of SGN-CD47M: Protease-activated antibody technology enables selective tumor targeting of the innate immune checkpoint receptor CD47. Mol Cancer Ther. 2024;: pubmed publisher
Roberts K, Cubitt M, Carlton T, Rodrigues Duarte L, Maggiore L, Chai R, et al. Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease. Sci Rep. 2021;11:19422 pubmed publisher
Alania Y, Creighton J, Trevelin L, Zamperini C, Bedran Russo A. Regional contribution of proteoglycans to the fracture toughness of the dentin extracellular matrix. J Biomech. 2020;101:109633 pubmed publisher
Devel L, Almer G, Cabella C, Beau F, Bernes M, Oliva P, et al. Biodistribution of Nanostructured Lipid Carriers in Mice Atherosclerotic Model. Molecules. 2019;24: pubmed publisher
Crowe J, Roberts K, Carlton T, Maggiore L, Cubitt M, Clare S, et al. Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease. Sci Rep. 2018;8:4941 pubmed publisher
Mikuła Pietrasik J, Uruski P, Sosińska P, Maksin K, Piotrowska Kempisty H, Kucińska M, et al. Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases. Cell Death Dis. 2016;7:e2565 pubmed publisher
Djokic J, Fagotto Kaufmann C, Bartels R, Nelea V, Reinhardt D. Fibulin-3, -4, and -5 are highly susceptible to proteolysis, interact with cells and heparin, and form multimers. J Biol Chem. 2013;288:22821-35 pubmed publisher
Devel L, Beau F, Amoura M, Vera L, Cassar Lajeunesse E, Garcia S, et al. Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins. J Biol Chem. 2012;287:26647-56 pubmed publisher
Zhao X, Qureshi F, Eastman P, Manning W, Alexander C, Robinson W, et al. Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis. J Immunol Methods. 2012;378:72-80 pubmed publisher
Zhou B, Peyton M, He B, Liu C, Girard L, Caudler E, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell. 2006;10:39-50 pubmed
product information
master code :
513-MP
SKU :
513-MP-010
product name :
Recombinant Human MMP-3 Protein, CF
unit size :
10 ug
description :
The Recombinant Human MMP-3 Protein, CF from R&D Systems is derived from NS0. The Recombinant Human MMP-3 Protein, CF has been validated for the following applications: Enzyme Activity.
target :
MMP-3
category :
Proteins and Enzymes
buffer :
Supplied as a 0.2 ╡m filtered solution in MES, NaCl, CaCl2, Glycerol and Brij-35.
conjugate :
Unconjugated
purity :
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
species :
Human
observed molecular weight :
54-56 kDa doublet, reducing conditions
theoretical molecular weight :
52 kDa
gene symbol :
MMP3
details of functionality :
Measured by its ability to cleave the fluorogenic peptide substrate, Mca-RPKPVE-Nval-WRK(Dnp)-NH2 (Catalog # ES002 ). The specific activity is 150 pmol/min/╡g, as measured under the described conditions.
endotoxin note :
<1.0 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
P08254
applications :
Enzyme Activity
source long :
Mouse myeloma cell line, NS0-derived human MMP-3 protein Tyr18-Cys477 (Lys45Glu)
source short :
NS0
USD :
444 USD
alt names :
CHDS6, EC 3.4.24, EC 3.4.24.17, matrix metallopeptidase 3 (stromelysin 1, progelatinase), matrix metalloproteinase 3 (stromelysin 1, progelatinase), Matrix metalloproteinase-3, MGC126102, MGC126103, MMP3, MMP-3, proteoglycanase, SL-1, STMY, STMY1MGC126104, STR1, Stromelysin 1, stromelysin-1, Transin-1
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 ░C as supplied. 3 months, -20 to -70 ░C under sterile conditions after opening.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.